Compare · EW vs MTRN
EW vs MTRN
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Materion Corporation (MTRN): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while MTRN operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $49.43B, about 10.5x MTRN ($4.69B).
- Over the past year, EW is up 14.7% and MTRN is up 179.9% - MTRN leads by 165.2 points.
- EW has been more active in the news (7 items in the past 4 weeks vs 2 for MTRN).
- EW has more recent analyst coverage (25 ratings vs 10 for MTRN).
- Company
- Edwards Lifesciences Corporation
- Materion Corporation
- Price
- $87.54+1.98%
- $227.77+0.66%
- Market cap
- $49.43B
- $4.69B
- 1M return
- +9.49%
- +14.22%
- 1Y return
- +14.69%
- +179.88%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 7
- 2
- Recent ratings
- 25
- 10
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Materion Corporation
Materion Corporation manufactures and sells advanced engineered materials used in semiconductor, industrial, aerospace and defense, automotive, energy, consumer electronics, and telecom and data center markets in the United States, Asia, Europe, and internationally. It operates through Performance Alloys and Composites, Advanced Materials, and Precision Optics segments. The Performance Alloys and Composites segment provides copper and nickel products in plate, rod, bar, tube, strip, wire product forms, as well as other customized shapes; precision strip products; beryllium hydroxide; and beryllium products, such as beryllium composites, ceramics, and engineered clad and plated metal systems, as well as aluminum silicon carbide metal matrix. This segment also produces strip metal products with clad inlay and overlay metals consisting of precious and base metal electroplated systems, electron beam welded systems, contour profiled systems, and solder-coated metal systems. The Advanced Materials segment provides advanced chemicals, microelectronics packaging, precious and non-precious metals, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms, high temperature braze materials, and ultra-pure wires. The Precision Optics segment produces sputter-coated precision thin film coatings and optical filter materials. It distributes its products through company-owned facilities, and independent distributors and agents. The company was formerly known as Brush Engineered Materials Inc. and changed its name to Materion Corporation in 2011. Materion Corporation was incorporated in 1931 and is headquartered in Mayfield Heights, Ohio.
Latest EW
- SEC Form 3 filed by new insider Mistras Theodora
- SVP, Corporate Controller Dahl Andrew M. sold $48,853 worth of shares (568 units at $86.08), decreasing direct ownership by 4% to 15,334 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $2,000,193 worth of shares (23,145 units at $86.42) (SEC Form 4)
- SEC Form SD filed by Edwards Lifesciences Corporation
- CVP, TMTT & Surgical Chopra Daveen sold $126,905 worth of shares (1,500 units at $84.60), decreasing direct ownership by 3% to 44,324 units (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 620 shares at a strike of $72.68 and sold $50,307 worth of shares (620 units at $81.14) as part of a pre-agreed trading plan (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $1,472,678 worth of shares (17,968 units at $81.96), decreasing direct ownership by 30% to 22,798 units (SEC Form 4)
- CEO Zovighian Bernard J converted options into 47,207 shares, covered exercise/tax liability with 26,198 shares, gifted 26,640 shares, received a gift of 26,640 shares and sold $2,833,013 worth of shares (36,351 units at $77.93) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 99,165 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr converted options into 13,457 shares and covered exercise/tax liability with 7,469 shares, increasing direct ownership by 22% to 32,766 units (SEC Form 4)
- CVP, TMTT & Surgical Chopra Daveen converted options into 13,583 shares and covered exercise/tax liability with 7,538 shares, increasing direct ownership by 15% to 45,824 units (SEC Form 4)
Latest MTRN
- Director Phillippy Robert J sold $765,164 worth of shares (3,500 units at $218.62), decreasing direct ownership by 49% to 3,664 units (SEC Form 4)
- SEC Form SD filed by Materion Corporation
- Materion Corporation to Participate in KeyBanc's Industrials & Basic Materials Conference on May 28
- Director Khilnani Vinod M sold $517,498 worth of shares (2,500 units at $207.00), decreasing direct ownership by 16% to 13,171 units (SEC Form 4)
- President and CEO Vijayvargiya Jugal K. exercised 28,071 shares at a strike of $50.95 and covered exercise/tax liability with 15,183 shares, increasing direct ownership by 11% to 129,587 units (SEC Form 4)
- Vice President, Finance & CFO Chadwick Shelly Marie sold $237,065 worth of shares (1,192 units at $198.88), exercised 4,912 shares at a strike of $113.28 and covered exercise/tax liability with 3,720 shares (SEC Form 4)
- Director Liggett Emily M converted options into 2,006 shares, increasing direct ownership by 53% to 5,782 units (SEC Form 4)
- Director Khilnani Vinod M converted options into 2,006 shares, increasing direct ownership by 15% to 15,671 units (SEC Form 4)
- Director Toth Robert B converted options into 2,006 shares, increasing direct ownership by 7% to 28,832 units (SEC Form 4)
- Director Solomon Darlene J. S. converted options into 2,006 shares, increasing direct ownership by 7% to 30,423 units (SEC Form 4)